Buy (150 RUB)
|Generate QR code
Open Access
Subscription or Fee Access
Impact of insomnia and its correction on quality of life of persons with disabilities
https://doi.org/10.33667/2078-5631-2023-21-14-22
Abstract
Aim. To study the effect of insomnia on the severity of the condition and on the quality of life in patients with disabilities.
Materials and methods. A prospective cohort study was conducted from 2019 to 2022, in which 100 patients took part. Patients with acute cerebrovascular accident (ACV) were selected as a clinical model of persons with disabilities. Two groups were formed from the total number of patients included in the study. 50 patients with acute cerebrovascular accident and suffering from insomnia constituted the main group, which was divided into 2 subgroups by a simple choice according to the random sampling rule in the Statistica 12 program. MG1 – the main subgroup 1–26 people who received, as part of complex therapy, a course of short-term (five sessions) cognitive-behavioral therapy for insomnia in combination with doxylamine at a dose of 15 mg 15–30 minutes before bedtime for 10 days. The second subgroup of the main group of patients (MG2) – 24 people who received only standard treatment. The comparison group (GS) (50 people) and a part (48 %) of the patients of the main group (24 people) also received only standard treatment for the underlying disease. All patients were assessed using the SF-36 Quality of Life Questionnaire, the Perrudet-Badoux, Mendelsohn, Chiche Subjective Wellbeing Scale (PSS), sleep quality questionnaires (Pittsburgh Sleep Quality Questionnaire and the Insomnia Severity Scale).
Results and conclusions. Against the background of the treatment in the main group 1, there was a reduction in insomnia, as well as an improvement in the quality of life on all scales of the quality of life questionnaire and more pronounced than in the comparison group and the main group 2. Thus, the correction of insomnia in addition to the basic therapy of post-stroke patients with limited opportunities allows you to achieve a more significant result of treatment than the use of only basic therapy for patients.
About the Authors
A. N. Akavov
Dagestan State Medical University
Russian Federation
Russian Federation
Akavov Adilkhan N., post-graduate student of Dept of Neurology
Makhachkala
E. A. Korabel'nikova
I. M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Korabel’nikova Elena A., DM Sci (habil.), professor at Dept of Nervous Diseases of Institute for Professional Education
Moscow
M. L. Baranov
Main Military Clinical Hospital of the National Guard Forces
Russian Federation
Russian Federation
Baranov Maksim L., PhD Med, psychotherapist at Centre of Rehabilitation Medicine
Balashikha
References
1. Karol E. V., Каntemirova R. K. Disability in the elderly owing to cerebrovascular diseases: the leading desadaptive syndromes. Adv Gerontol. 2017; 30 (2): 215-222. Russian. PMID: 28575560.
2. Wafa H. A., Wolfe C. D.A., Emmett E., Roth G. A., Johnson C. O., Wang Y. Burden of Stroke in Europe: Thirty-Year Projections of Incidence, Prevalence, Deaths, and Disability-Adjusted Life Years. Stroke. 2020; 51 (8): 2418-2427. Epub 2020 Jul 10. PMID: 32646325; PMCID: 7382540. https://doi.org/10.1161/strokeaha.120.029606
3. Hepburn M., Bollu P. C., French B., Sahota P. Sleep Medicine: Stroke and Sleep. Mo Med. 2018; 115 (6): 527-532. PMID: 30643347; PMCID: 6312177.
4. Tang W. K., Grace Lau C., Mok V., Ungvari G. S., Wong K. S. Insomnia and health-related quality of life in stroke. Top Stroke Rehabil. 2015; 22 (3): 201-207. Epub 2015 Apr 23. PMID: 25908494. https://doi.org/10.1179/1074935714z.0000000026
5. Buysse D. J. Insomnia. JAMA. 2013; 309 (7): 706-16. PMID: 23423416; PMCID: PMC: 3632369. https://doi.org/10.1001/jama.2013.193
6. Bollu P. C., Kaur H. Sleep Medicine: Insomnia and Sleep. Mo Med. 2019; 116 (1): 68-75. PMID: 30862990; PMCID: 6390785.
7. Perlis M. L., Posner D., Riemann D., Bastien C. H., Teel J., Thase M. Insomnia. Lancet. 2022; 400 (10357): 1047-1060. Epub 2022 Sep 14. PMID: 36115372. https://doi.org/10.1016/S0140-6736(22)00879-0
8. Meneo D., Samea F., Tahmasian M., Baglioni C. The emotional component of insomnia disorder: A focus on emotion regulation and affect dynamics in relation to sleep quality and insomnia. J Sleep Res. 2023: e13983. Epub ahead of print. PMID: 37394234. https://doi.org/10.1111/jsr.13983
9. Maalouf E., Hallit S., Salameh P., Hosseini H. Depression, anxiety, insomnia, stress, and the way of coping emotions as risk factors for ischemic stroke and their influence on stroke severity: A case-control study in Lebanon. Front Psychiatry. 2023; (14): 1097873. PMID: 36896347; PMCID: 9988919. https://doi.org/10.3389/fpsyt.2023.1097873
10. Niu S., Liu X., Wu Q., Ma J., Wu S., Zeng L., Shi Y. Sleep Quality and Cognitive Function after Stroke: The Mediating Roles of Depression and Anxiety Symptoms. Int J Environ Res Public Health. 2023; 20 (3): 2410. PMID: 36767777; PMCID: 9915208. https://doi.org/10.3390/ijerph20032410
11. Batalla-Martín D., Belzunegui-Eraso A., Miralles Garijo E., Martínez Martín E., Romaní Garcia R., Heras J. S.M., Lopez-Ruiz M., Martorell-Poveda M. A. Insomnia in Schizophrenia Patients: Prevalence and Quality of Life. Int J Environ Res Public Health. 2020; 17 (4): 1350. PMID: 32093111; PMCID: 7068578. https://doi.org/10.3390/ijerph17041350
12. Fanielle J. Sleep disorders in connection with somatic symptom disorders. Rev Med Liege. 2023; 78 (5-6): 296-298. French. PMID: 37350205.
13. Korabelnikova E. A. Insomnia in patients with anxiety disorders. Effective pharmacotherapy. 2016; (19): 44-51. EDN WIEOWJ.
14. Poluektov M. G., Akarachkova E. S., Dovgan E. V., Kotova O. V., Demidova T. Yu., Klimenko A. A., Kokorin V. A., Ostroumova O. D., Ostroumova T. .M. Management of patients with insomnia in multimorbid pathology: Expert consensus. Journal of Neurology and Psychiatry n. a. S. S. Korsakov. Special issues. 2023; 123 (5-2): 49-57.
15. Burchakov D. I., Tardov M. V. Insomnia in the practice of a therapist: The role of doxylamine. Medical Counsil. 2020; (2): 45-53. https://doi.org/10.21518/2079-701x-2020-2-45-53.
16. Hausser Hauw C., Fleury B., Scheck F., Pello J. Y., Lebeau B. Effect on sleep architecture and residual effect of a dose of 15 mg of Doxylamine in healthy volunteers. Sep Hop Paris. 1995; 71: 23-24, 742-750.
Review
For citations:
Akavov A.N., Korabel'nikova E.A., Baranov M.L. Impact of insomnia and its correction on quality of life of persons with disabilities. Medical alphabet. 2023;(21):14-22. (In Russ.) https://doi.org/10.33667/2078-5631-2023-21-14-22
Views:
286
Email this article 